FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE Keystone, E., Genovese, M. C., Hall, S., Miranda, P. C., Bae, S., Han, C., Gathany, T., Zhou, Y., Xu, S., Hsia, E. C. OXFORD UNIV PRESS. 2014: 99

View details for DOI 10.1093/rheumatology/keu101.031

View details for Web of Science ID 000364513000284